CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. (Q52970972)
Jump to navigation
Jump to search
scientific article published in June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. |
scientific article published in June 2000 |
Statements
CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. (English)
1 reference
Qin Z
1 reference
Blankenstein T
1 reference
1 June 2000
1 reference
1 reference
12
1 reference
677-686
1 reference
6
1 reference
Identifiers
1 reference